Radioimmunotherapy for Treatment of Acute Leukemia

Acute leukemias are characterized by accumulation of immature cells (blasts) and reduced production of healthy hematopoietic elements. According to the lineage origin, two major leukemias can be distinguished: acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL). Although the survival rate for pediatric ALL is close to 90%, half of the young adults with AML or ALL and approximately 90% of older patients with AML or ALL still die of their disease, raising the need for innovative therapeutic approaches.

Source: Seminars in Nuclear Medicine - February 19, 2016 Category: Nuclear Medicine Authors: Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Thomas Eugène, François Guérard, Joëlle Gaschet, Clément Bailly, Marie Mougin, Mickaël Bourgeois, Alain Faivre-Chauvet, Michel Chérel, Patrice Chevallier Source Type: research